Ekos Announces a Groundbreaking Study for the Treatment of Intracerebral and Intraventricular Hemorrhage Using Ultrasound Presented at the American Heart AssociationInternational Stroke Conference 2010

BOTHELL, Wash.--(BUSINESS WIRE)--EKOS Corporation announced today that Dr. David W. Newell, Co–Executive Director, Swedish Neuroscience Institute (SNI, Seattle, WA) presented a SNI clinical study known as ‘SLEUTH’ (Safety of Lysis with Ultrasound in the Treatment of Intracerebral (ICH) and Intraventricular Hemorrhage (IVH) at the American Heart Association International Stroke Conference (San Antonio, TX).